NEW YORK (GenomeWeb News) – Cepheid said yesterday that the Connecticut Hospital Association Shared Services Program for molecular surveillance of methicillin-resistant Staphylococcus aureus has selected Cepheid as its vendor of choice for the tests.
 
The CHA, which has 164 acute-care member hospitals, will exclusively market Cepheid’s GeneXpert Systems and Xpert MRSA test to its hospitals at pre-negotiated prices.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.